A 34-year-old man suffering from Hodgkin's disease underwent high-dose chemotherapy (CBV) followed by transplantation of autologous peripheral blood stem cells. On day +6 after peripheral blood stem cell transplant (PBSCT) bacterial pneumonia developed. Along with rapid engraftment during stimulation with G-CSF adult respiratory distress syndrome (ARDS) developed within 4 days. High-flow CPAP (continuous positive airway pressure) ventilation via a sealed face-mask was initiated. The patient tolerated the sealed face-mask very well, and CPAP was continuously administered for 4 days, thus avoiding intubation. High-flow CPAP may offer a therapeutic alternative in selected patients with respiratory compromise after PBSCT. Keywords: high-dose chemotherapy and peripheral blood progenitor cell rescue; non-invasive ventilatory support; non-invasive ventilation; CPAP; ARDS Pulmonary complications during the first 100 days after BMT leading to intubation and mechanical ventilation are associated with an extremely poor prognosis.
Pulmonary complications during the first 100 days after BMT leading to intubation and mechanical ventilation are associated with an extremely poor prognosis. [1] [2] [3] [4] Therefore, restricted use of mechanical ventilation has been called for. 4 Increasing experience with non-invasive methods of respiratory support not necessarily warranting a transfer to the intensive care unit could be an alternative to keep patients in the BMT unit without an endotracheal tube for as long as possible. Physicians and nurses well trained in respiratory support services and the appropriate technical facilities are prerequisites to perform these therapies in a BMT unit. We report the case of a patient with ARDS in whom non-invasive respiratory support avoided intubation. 
Case report
A previously healthy 34-year-old man, in whom Hodgkin's disease was diagnosed 13 years prior to admission, was admitted to our hospital for high-dose chemotherapy followed by autologous peripheral blood stem cell rescue (PBSCT).
Relapse of the disease had occurred 10 years and 1 year before admission, respectively. Remission status prior to transplantation was responsive relapse. Physical examination was unremarkable. The lungs had never been involved by the lymphoma. After myeloablative chemotherapy consisting of 576 mg BCNU, 2880 mg cyclophosphamide and 480 mg etoposide (CBV), 4.85 × 10 6 CD34-positive cells/kg BW were infused. Granulocyte colony-stimulating factor (G-CSF) was administered at a dose of 5 g/kg as a continuous intravenous infusion starting on day +1 after PBSCT. On day +5 after PBSCT antibiotic therapy consisting of pipercillin/tazobactam was initiated because of high fevers up to 39.5°C. On day +6 chest X-rays disclosed dense shadowing in the left lower lobe consistent with bacterial or fungal pneumonia. The patient presented mildly dyspneic with an arterial oxygen saturation measured by pulse oximetry of 94% without oxygen supplementation. Antibiotics were changed to imipenem, teicoplanin, and amphotericin B due to persistent fever. On day +9, the absolute neutrophil count (ANC) reached 0.5 × 10 9 /l and 1.0 × 10 9 /l on day +11 after PBSCT. G-CSF was discontinued on day +9. Along with engraftment, the respiratory situation worsened dramatically. With 15 liters of oxygen via a non-sealing face mask the respiratory rate was 58/min, PaO 2 56 mm Hg, PaCO 2 45 mmHg and the pH 7.45 on day +9. Chest X-rays showed bilateral patchy alveolar densities diffusely distributed over both lungs consistent with adult respiratory distress syndrome (ARDS) (Figure 1 ). Highflow CPAP (continuous positive airway pressure) ventilation via a sealed face-mask was initiated with a fraction of inspired oxygen (FiO 2 ) of 0.8 and a positive endexpiratory pressure (PEEP) of 5 mbar. The same day, FiO 2 and PEEP had to be increased to 1.0 and 10 mbar, respectively, to maintain adequate oxygenation. Since the patient tolerated the sealed face-mask well, intubation was avoided. Continuous CPAP ventilation was maintained for 4 days. Sup- plemental therapy consisted of 250 mg of prednisolone on days +9 to +12, generous transfusion of packed red blood cells (RBC) to keep hemoglobin levels above 10 g/dl and diuretics to achieve a negative fluid balance. On day +13 oxygenation improved slowly so that FiO 2 and PEEP could be reduced gradually to 0.5 and 5 mbar, respectively. sealing face-mask. Further improvement of the respiratory situation allowed weaning from oxygen on day +30 and the patient was discharged on day +37 without being dyspneic at rest. Figure 3 shows the chest radiograph on the day prior to discharge. Eighteen months after BMT the patient remains in complete hematological remission without any signs of respiratory impairment.
Discussion
Respiratory complications during the first 100 days after bone marrow transplantation (BMT) or peripheral blood stem cell transplantation (PBSCT) occur in up to 50% of patients. 5, 6 Despite broad-spectrum antibiotic, antifungal and antiviral therapy, pulmonary complications occur commonly in patients after BMT and often lead to life-threatening respiratory failure. 2, 5, 6 Decreased pulmonary function sometimes requires ventilatory support, and varies from oxygen supplementation to intubation and mechanical ventilation. Patients who need mechanical ventilation during the first 100 days after BMT have an extremely poor prognosis, [1] [2] [3] [4] and infections are a leading cause of death. In our patient, a pulmonary bacterial infection probably caused by Pseudomonas aeruginosa led to a fulminant increase of leukocytes during stimulation with G-CSF which together with leukocyte attraction to the site of infection likely caused cytokine-mediated increase of vascular permeability leading to ARDS within 4 days. Specific and supportive therapy consisted of empiric broad-spectrum antibiotics, corticosteroids to suppress the overwhelming inflammatory process, generous transfusion of packed red blood cells to optimize oxygen delivery and a negative fluid balance to improve interstitial pulmonary edema. To maintain adequate oxygenation continuous positive airway pressure (CPAP) ventilation via a sealed face mask was initiated. CPAP is a readily available and effective method of ventilation. 7, 8 During CPAP a continuous positive pressure is delivered throughout the respiratory cycle, either by a portable compressor or from a flow generator in conjunction with a reservoir and a high pressure gas source. A positive end-expiratory pressure (PEEP) is maintained by a pressure valve at the expiratory end of the tubing. Advantages are the recruitment of alveoli and the ensuing improvement of a ventilation/perfusion mismatch by the effects of PEEP and reduced work of breathing. 9 A perfectly sealed mask is essential to maintain positive airway pressure. Disadvantages are the need for continuing spontaneous breathing, the persistent danger of aspiration and retention of gastric and airway secretions, as well as difficulties with expiration in some patients with loss of chest wall or lung elasticity. Active muscle effort may be required during expiration. Excellent patient compliance is of uppermost importance. Many patients cannot tolerate the often painful and annoying mask for a longer period of time. Adequate information about the purpose of the therapy and mild sedation can be helpful in these patients.
Other methods of non-invasive ventilatory support additionally augmenting inspiration such as pressure support, 10 time-cycled volume or pressure controlled ventilation, 11 and recently, proportional assist ventilation 12 could offer new possibilities for keeping patients without an endotracheal tube for as long as possible.
Besides the technical equipment, specially trained nurses and physicians are necessary to provide the high level of respiratory support necessary for the management of the severely compromised respiratory function in BMT patients. In addition, experienced critical care physicians may be involved in the decision process regarding the different methods of ventilatory support, as is the case at our center. Under these circumstances, it may be an advantage for the severely immunocompromised BMT patient to receive his respiratory treatment in the BMT unit in a semisterile or sterile environment.
Our case shows that successful management of patients with respiratory failure can be performed in BMT units with appropriate respiratory support services.
